# Safety and Efficacy of IDP-122 in the Treatment of Participants With Plaque Psoriasis

> **NCT02515097** · PHASE3 · COMPLETED · sponsor: **Bausch Health Americas, Inc.** · enrollment: 213 (actual)

## Conditions studied

- Plaque Psoriasis

## Interventions

- **DRUG:** IDP-122 Lotion
- **DRUG:** IDP-122 Vehicle Lotion

## Key facts

- **NCT ID:** NCT02515097
- **Lead sponsor:** Bausch Health Americas, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11-05
- **Primary completion:** 2017-03-15
- **Final completion:** 2017-03-15
- **Target enrollment:** 213 (ACTUAL)
- **Last updated:** 2020-01-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02515097

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02515097, "Safety and Efficacy of IDP-122 in the Treatment of Participants With Plaque Psoriasis". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02515097. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*